Health and Healthcare

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

584 Articles

Chris Lange | Apr 26, 2017 at 11:30 AM EDT

AbbVie, Celgene and 2 More Major Biotechs Reporting Earnings Thursday

24/7 Wall St. has put together a preview of some of the world’s largest biotech and pharma companies reporting their…

Chris Lange | Apr 26, 2017 at 8:25 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Pharma

The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Lee Jackson | Apr 17, 2017 at 10:00 AM EDT

Top Dividend Pharmaceutical Stocks Safe Bet for Rest of 2017

With interest rates once again dropping as the geopolitical worries ratchet up, investors are concerned about owning good stocks and…

Chris Lange | Apr 12, 2017 at 8:25 AM EDT

Short Sellers Run for Cover From Major Pharma Stocks

The March 31 short interest data have been compared with the previous figures, and short interest decreased in most of…

Chris Lange | Mar 27, 2017 at 8:35 AM EDT

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

The March 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Mar 20, 2017 at 10:55 AM EDT

Monday’s Top Biopharma Movers

Esperion Therapeutics and a few other biopharma stocks made massive runs on Monday morning.

Chris Lange | Mar 10, 2017 at 8:55 AM EST

Short Sellers Back Off Major Pharma

The February 28 short interest data have been compared with the previous figures, and short interest in most of these…

Lee Jackson | Mar 5, 2017 at 10:20 AM EST

Insider Buying Steady as Market Again Hits All-Time Highs: Arconic, Murphy’s USA, Bristol-Myers, Avon and More

Giddy investors continued pouring money into U.S. stocks last week, and insiders continued their steady purchases at companies where they…

Chris Lange | Feb 28, 2017 at 8:55 AM EST

Why Short Sellers Are Making a Massive Bet in Major Pharma

Judging by this report, short sellers are making a tremendous bet against Trump’s plan to reform the health care sector.

Jon C. Ogg | Feb 21, 2017 at 10:55 AM EST

3 Big Companies Buckling to Activist Investors

Tuesday, February 21, 2017, saw three large companies in the news after activist investors have targeted them. Investors have taken…

Paul Ausick | Feb 16, 2017 at 12:45 PM EST

Apple Named World’s Most Innovative Company

2016's 50 most innovative companies are topped by Apple, Google and Tesla. Among the companies making the biggest moves were…

Chris Lange | Feb 10, 2017 at 8:35 AM EST

Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?

It has yet to be seen how much headway Trump can actually make with heath care reforms, but so far…

Paul Ausick | Jan 26, 2017 at 4:04 PM EST

Bristol-Myers, Mattel Plunge into Thursday’s 52-Week Low Club

Bristol-Myers, Mattel, DryShips, and FuelCell Energy posted new 52-week lows Thursday.

Chris Lange | Jan 26, 2017 at 9:50 AM EST

Short Sellers Run for Cover From Major Pharma

The January 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Paul Ausick | Jan 25, 2017 at 4:04 PM EST

Bristol-Myers, DryShips Drop into Wednesday’s 52-Week Low Club

Bristol-Myers, DryShips, Michaels, and Meridian Bioscience sink into Wednesday's 52-week low club.

1 … 19 20 21 22 23 … 39

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

AbbVie, Celgene and 2 More Major Biotechs Reporting Earnings Thursday

Short Sellers Can’t Make Up Their Minds on Major Pharma

Top Dividend Pharmaceutical Stocks Safe Bet for Rest of 2017

Short Sellers Run for Cover From Major Pharma Stocks

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

Monday’s Top Biopharma Movers

Short Sellers Back Off Major Pharma

Insider Buying Steady as Market Again Hits All-Time Highs: Arconic, Murphy’s USA, Bristol-Myers, Avon and More

Why Short Sellers Are Making a Massive Bet in Major Pharma

3 Big Companies Buckling to Activist Investors

Apple Named World’s Most Innovative Company

Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?

Bristol-Myers, Mattel Plunge into Thursday’s 52-Week Low Club

Short Sellers Run for Cover From Major Pharma

Bristol-Myers, DryShips Drop into Wednesday’s 52-Week Low Club

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Why Affluent Couples Are Draining the Higher-Earning Spouse's 401(k) First to Avoid the Widow's Tax Penalty

Middle-Class Fortysomethings Have a $427,000 Problem and a Shrinking Window to Fix It

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

AbbVie, Celgene and 2 More Major Biotechs Reporting Earnings Thursday

Short Sellers Can’t Make Up Their Minds on Major Pharma

Top Dividend Pharmaceutical Stocks Safe Bet for Rest of 2017

Short Sellers Run for Cover From Major Pharma Stocks

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

Monday’s Top Biopharma Movers

Short Sellers Back Off Major Pharma

Insider Buying Steady as Market Again Hits All-Time Highs: Arconic, Murphy’s USA, Bristol-Myers, Avon and More

Why Short Sellers Are Making a Massive Bet in Major Pharma

3 Big Companies Buckling to Activist Investors

Apple Named World’s Most Innovative Company

Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?

Bristol-Myers, Mattel Plunge into Thursday’s 52-Week Low Club

Short Sellers Run for Cover From Major Pharma

Bristol-Myers, DryShips Drop into Wednesday’s 52-Week Low Club

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Featured Reads

Why Affluent Couples Are Draining the Higher-Earning Spouse's 401(k) First to Avoid the Widow's Tax Penalty

Middle-Class Fortysomethings Have a $427,000 Problem and a Shrinking Window to Fix It